BCL2L2 Antikörper (PE)
Kurzübersicht für BCL2L2 Antikörper (PE) (ABIN759591)
Target
Alle BCL2L2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Kreuzreaktivität
- Maus
-
Homologie
- Human,Rat,Dog,Pig,Horse,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human Bcl2L2
-
Isotyp
- IgG
-
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- BCL2L2 (BCL2-Like 2 (BCL2L2))
-
Andere Bezeichnung
- Bcl2L2
-
Hintergrund
-
Synonyms: Apoptosis regulator BCL W, Apoptosis regulator Bcl-W, B2CL2_HUMAN, BCL 2 Like 2, Bcl 2 like 2 protein, Bcl 2L2, BCL W, Bcl-2-like protein 2, Bcl2 L2, BCL2 like 2, BCL2 like 2 protein, Bcl2-L-2, Bcl2l2, BCLW.
Background: Promotes cell survival. Blocks dexamethasone-induced apoptosis. Mediates survival of postmitotic Sertoli cells by suppressing death-promoting activity of BAX.
-
Molekulargewicht
- 21kDa
-
Gen-ID
- 599
Target
-